Notice: This company has been marked as potentially delisted and may not be actively trading. Digirad (DRAD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends DRAD vs. NXL, OM, POCI, BSGM, PTHL, IRIX, NRXS, MOVE, QTI, and STRRShould you be buying Digirad stock or one of its competitors? The main competitors of Digirad include Nexalin Technology (NXL), Outset Medical (OM), Precision Optics (POCI), BioSig Technologies (BSGM), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), IRIDEX (IRIX), NeurAxis (NRXS), Movano (MOVE), QT Imaging (QTI), and Star Equity (STRR). Digirad vs. Nexalin Technology Outset Medical Precision Optics BioSig Technologies Pheton Holdings Ltd Class A Ordinary Shares IRIDEX NeurAxis Movano QT Imaging Star Equity Nexalin Technology (NASDAQ:NXL) and Digirad (NASDAQ:DRAD) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends. Does the MarketBeat Community prefer NXL or DRAD? Digirad received 317 more outperform votes than Nexalin Technology when rated by MarketBeat users. However, 100.00% of users gave Nexalin Technology an outperform vote while only 70.35% of users gave Digirad an outperform vote. CompanyUnderperformOutperformNexalin TechnologyOutperform Votes1100.00% Underperform VotesNo VotesDigiradOutperform Votes31870.35% Underperform Votes13429.65% Which has more volatility and risk, NXL or DRAD? Nexalin Technology has a beta of 3.5, meaning that its stock price is 250% more volatile than the S&P 500. Comparatively, Digirad has a beta of 0.18, meaning that its stock price is 82% less volatile than the S&P 500. Is NXL or DRAD more profitable? Digirad has a net margin of -5.32% compared to Nexalin Technology's net margin of -3,407.98%. Digirad's return on equity of -3.75% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-3,407.98% -187.59% -167.21% Digirad -5.32%-3.75%-0.85% Does the media prefer NXL or DRAD? In the previous week, Nexalin Technology had 4 more articles in the media than Digirad. MarketBeat recorded 4 mentions for Nexalin Technology and 0 mentions for Digirad. Nexalin Technology's average media sentiment score of 0.24 beat Digirad's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the media. Company Overall Sentiment Nexalin Technology Neutral Digirad Neutral Do institutionals and insiders hold more shares of NXL or DRAD? 0.7% of Nexalin Technology shares are held by institutional investors. Comparatively, 11.4% of Digirad shares are held by institutional investors. 24.0% of Nexalin Technology shares are held by company insiders. Comparatively, 12.5% of Digirad shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, NXL or DRAD? Digirad has higher revenue and earnings than Nexalin Technology. Digirad is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$110K493.36-$4.65M-$0.64-6.59Digirad$114.18M0.13-$4.63M-$0.35-9.06 Do analysts prefer NXL or DRAD? Nexalin Technology currently has a consensus price target of $3.00, suggesting a potential downside of 28.91%. Given Nexalin Technology's stronger consensus rating and higher possible upside, analysts plainly believe Nexalin Technology is more favorable than Digirad.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Digirad 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNexalin Technology and Digirad tied by winning 9 of the 18 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Digirad News Delivered to You Automatically Sign up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRAD vs. The Competition Export to ExcelMetricDigiradElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.09M$3.61B$5.18B$8.74BDividend Yield83.65%1.65%5.19%4.08%P/E Ratio-1.0114.7867.7214.54Price / Sales0.1396.981,247.6286.91Price / Cash0.6946.1739.9635.24Price / Book0.313.806.495.93Net Income-$4.63M$92.21M$120.21M$225.73M Digirad Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRADDigiradN/A$3.17+2.3%N/A+237.3%$15.09M$114.18M-1.01618NXLNexalin Technology1.0789 of 5 stars$4.22+2.9%$3.00-28.9%+1,283.6%$54.28M$110,000.00-6.593Earnings ReportShort Interest ↑OMOutset Medical2.5882 of 5 stars$0.79-8.1%$4.70+493.5%-84.3%$41.61M$130.38M-0.29520POCIPrecision Optics0.9151 of 5 stars$5.23+10.6%N/A-12.1%$33.21M$19.10M-8.4480Short Interest ↓News CoverageGap UpBSGMBioSig TechnologiesN/A$1.82+15.2%N/A-48.6%$31.18M$20,000.000.0050News CoverageGap UpPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$4.35+4.6%N/AN/A$28.63MN/A0.0011Positive NewsGap UpIRIXIRIDEX0.7217 of 5 stars$1.69-4.5%$2.00+18.3%-15.5%$28.12M$49.70M-2.52120Earnings ReportAnalyst ForecastShort Interest ↓News CoverageNRXSNeurAxisN/A$3.15-3.7%N/A+23.0%$21.99M$2.46M-1.7119News CoverageGap UpMOVEMovano2.3213 of 5 stars$3.21-8.8%$30.00+834.6%-75.0%$21.19MN/A-0.6330Short Interest ↓News CoverageGap UpQTIQT ImagingN/A$0.57+16.4%N/AN/A$12.42MN/A0.00N/AInsider BuyingShort Interest ↓News CoveragePositive NewsGap UpHigh Trading VolumeSTRRStar Equity2.1789 of 5 stars$3.17+2.3%N/A-32.5%$10.24M$45.78M-1.14171Upcoming EarningsNews Coverage Related Companies and Tools Related Companies Nexalin Technology Competitors Outset Medical Competitors Precision Optics Competitors BioSig Technologies Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors IRIDEX Competitors NeurAxis Competitors Movano Competitors QT Imaging Competitors Star Equity Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DRAD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRAD Stock Alerts